ACIR BioSciences

ACIR BioSciences is a specialized contract research organization (CRO) that provides advanced immunology services to the biopharmaceutical industry, with a focus on supporting the development of vaccines and cell therapies. The company specializes in high-resolution immune profiling, utilizing high-parameter flow cytometry and functional T-cell assays to provide deep insights into therapeutic mechanisms of action. Founded by world-renowned immunologists, ACIR BioSciences offers end-to-end immunomonitoring solutions for clinical trials, ranging from assay development to sample analysis. In early 2021, the company was acquired by Nexelis to enhance its global immunology capabilities, and it was subsequently integrated into Q2 Solutions, a subsidiary of IQVIA. The organization continues to serve as a critical partner for companies developing complex immunotherapies and infectious disease treatments.